PubRank

Domenico Sergi

Author PubWeight™ 24.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon. J Cardiovasc Electrophysiol 2011 2.67
2 Clinical and procedural outcome of patients implanted with a quadripolar left ventricular lead: early results of a prospective multicenter study. Heart Rhythm 2012 1.08
3 Immunologic treatments for precancerous lesions and uterine cervical cancer. J Exp Clin Cancer Res 2014 0.96
4 Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer. Breast Cancer Res Treat 2013 0.94
5 The outcome of intra-aortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock according to the type of revascularization: a comprehensive meta-analysis. Am Heart J 2013 0.91
6 Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study. Breast Cancer Res Treat 2014 0.88
7 Improved implant and postoperative lead performance in CRT-D patients implanted with a quadripolar left ventricular lead. A 6-month follow-up analysis from a multicenter prospective comparative study. J Interv Card Electrophysiol 2014 0.88
8 Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials. PLoS One 2013 0.87
9 A phase II trial of docetaxel and vinorelbine in patients with advanced breast cancer previously treated with anthracyclines. Oncology 2008 0.85
10 Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series. Breast Cancer Res Treat 2014 0.85
11 Aromatase inhibitors for metastatic male breast cancer: molecular, endocrine, and clinical considerations. Breast Cancer Res Treat 2014 0.84
12 A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study. J Exp Clin Cancer Res 2011 0.83
13 Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma. J Exp Clin Cancer Res 2009 0.83
14 Anthropometric, metabolic and molecular determinants of human epidermal growth factor receptor 2 expression in luminal B breast cancer. J Cell Physiol 2015 0.81
15 Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer. Gastric Cancer 2013 0.81
16 Impact of continuous intracardiac ST-segment monitoring on mid-term outcomes of ICD-implanted patients with coronary artery disease. Early results of a prospective comparison with conventional ICD outcomes. Heart 2011 0.80
17 Hemodynamic patterns of residual interatrial communication after transcatheter MitraClip repair. J Cardiovasc Med (Hagerstown) 2014 0.79
18 FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort. J Exp Clin Cancer Res 2013 0.79
19 Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients. J Exp Clin Cancer Res 2013 0.78
20 Long-term exposure to a high-fat diet results in the development of glucose intolerance and insulin resistance in interleukin-1 receptor I-deficient mice. Am J Physiol Endocrinol Metab 2013 0.78
21 [Iatrogenic risk of permanent pacemaker and defibrillator implantation]. G Ital Cardiol (Rome) 2009 0.78
22 Large coronary aneurysm following laser angioplasty of the left anterior descending coronary artery. J Cardiovasc Med (Hagerstown) 2012 0.78
23 Lack of intra-aortic balloon pump effectiveness in high-risk percutaneous coronary interventions without cardiogenic shock: a comprehensive meta-analysis of randomised trials and observational studies. Int J Cardiol 2013 0.77
24 Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines. Cancer Chemother Pharmacol 2010 0.77
25 First clinical experience with the new four-pole standard connector for high-voltage ICD leads. Early results of a multicenter comparison with conventional implant outcomes. J Interv Card Electrophysiol 2013 0.77
26 A novel methodology for AV and VV delay optimization in CRT: results from a randomized pilot clinical trial. J Artif Organs 2013 0.76
27 Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction. J Cardiovasc Med (Hagerstown) 2011 0.76
28 Pharmacogenetics in cardiovascular disorders: an update on the principal drugs. Am J Cardiovasc Drugs 2013 0.76
29 Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines. Anticancer Res 2009 0.76
30 Unusual long-lasting cutaneous complete response to lapatinib and capecitabine in a heavily pretreated HER2-positive plurimetastatic breast cancer patient. Tumori 2013 0.76
31 Trial sequential analysis: the role of the number needed-to-treat in evaluating the clinical relevance of relative risk reduction values in the intra-aortic balloon pump support. Int J Cardiol 2013 0.75
32 Arrhythmogenic right-ventricular cardiomyopathy and cardiac microvascular disease: a rare association or a possible link? J Cardiovasc Med (Hagerstown) 2017 0.75
33 Laparoscopic Debulking Surgery in the Management of Advanced Ovarian Cancer After Neoadjuvant Chemotherapy. Int J Gynecol Cancer 2015 0.75
34 A rare case of multiple thrombi in a giant left atrium. J Cardiovasc Med (Hagerstown) 2017 0.75
35 Percutaneous closure of patent foramen ovale with Atriasept II device in nickel allergic patients. J Cardiovasc Med (Hagerstown) 2014 0.75
36 Transcatheter closure of paravalvular leak secondary to left ventricular peri-annular pseudoaneurysm. Eur Heart J Cardiovasc Imaging 2013 0.75
37 Transcatheter aortic valve implantation through distal axillary artery: novel option for vascular access. J Cardiovasc Med (Hagerstown) 2015 0.75
38 Early detection of high voltage lead failure with an unusual and unexpected device alert. Heart 2013 0.75
39 Endothelial dysfunction is a marker of systemic response to the cardiac resynchronization therapy in heart failure. J Card Fail 2013 0.75
40 Clinical and electrical performance of currently available MRI-safe pacing systems. Do all devices perform in the same way? Int J Cardiol 2012 0.75
41 Device monitoring of heart failure in cardiac resynchronization therapy device recipients: a single-center experience with a novel multivector impedance monitoring system. J Cardiovasc Med (Hagerstown) 2013 0.75
42 Percutaneous aortic leak closure in a small and frail annulus after double heart valve replacement. J Cardiovasc Med (Hagerstown) 2017 0.75
43 Surgical and Oncological Outcome of Robotic Surgery Compared With Laparoscopic and Abdominal Surgery in the Management of Locally Advanced Cervical Cancer After Neoadjuvant Chemotherapy. Int J Gynecol Cancer 2016 0.75
44 Hot flushes in women with breast cancer: state of the art and future perspectives. Expert Rev Anticancer Ther 2013 0.75